Lipid & Cardiovascular Risk Management in the Era of COVID-19

Date: July 09, 2020 @ 20.30-21.30 (Time Zone: GMT+3, Saudi Arabia)

Presented by: Dr. Nasreen Alsayed

Moderated by: Dr. Tarik Elhadd

Dr. Tarik Elhadd 
Senior Consultant Endocrinologist
Hamad Medical Corporation, Qatar Metabolic Institute
Doha, Qatar

View Bio

Dr. Tarik A. A. El Hadd qualified from the Faculty of Medicine, Khartoum University, Sudan and then pursued higher medical training in the UK. In 1995 he obtained an MRC research fellowship at Dundee University, Scotland, followed by an MD with a theme of endothelial dysfunction in diabetes. Dr. El Hadd completed specialist training in General Internal Medicine, Diabetes and Endocrinology with CCST at the Professorial Department of Endocrinology at North Staffordshire Hospital, Stoke-on-Trent, England. In 2000, he was appointed to the first Consultant post in the UK at Dudley Group of Hospitals in West Midlands, England. Between 2003 – 2006 he held the post of Consultant Endocrinologist at King Faisal Specialist Hospital and Research Centre in Jeddah, Saudi Arabia, followed by the post of Consultant Physician and Endocrinologist at Ayr Hospital, Scotland. In 2009 he was appointed to a personal chair at the University of Medical Sciences and Technology in Khartoum, Sudan. He subsequently held several consultant posts in the UK, before moving to Hamad Medical Corporation in October 2014. Dr. El Hadd served as a peer reviewer for several journals, including the Diabetic Medicine, Annals of Saudi Medicine, Endocrine Practice and Clinica Acta Medica. He currently serves as Associate Editor of the Sudan Medical Journal. Dr. El Hadd has been invited to speak at several professional endocrine and diabetes meetings. He has authored and co-authored more than 50 articles in peer reviewed journals and several book chapters. Dr. El Hadd is a Fellow of the Royal Colleges of Physicians of London and Edinburgh, a Fellow of the American College of Endocrinology and a member of several European and American professional associations. He sits in several hospital committees including HMC, IRB Committee, DSMP Committee at Weil Cornell Medical College, Doha and Medical Scientific Committee of the Endocrine Section at Qatar Metabolic Institute, HMC.

Dr. Nasreen Alsayed
Consultant Endocrinologist and Lipidologist
Gulf Medical and Diabetes Center
Manama, Bahrain

View Bio

Dr. Al-Sayed graduated from Arabian Gulf University, college of Medicine in Bahrain. She is American Board Certified. She completed her Residency training in Internal medicine at Sinai-Grace Hospital, Wayne State University, Detroit, Michigan, USA and Fellowship training in Endocrinology and Diabetes at Cleveland Clinic Foundation, Ohio, USA. Dr. Al-Sayed is also American Board Certified in Clinical Lipidology and a fellow of American College of Physicians and fellow of American College of Endocrinologists. She has worked as assistant professor at Arabian Gulf University and is currently at Gulf Diabetes Specialist Center in Bahrain. Dr. Al-Sayed is a member of the National Lipid Association and other Diabetes and Endocrine Associations and has several research publications. She is a member of Board of Directors of the American Association of Clinical Endocrinologist, Gulf Chapter and a member of expert panel for Middle East Familial Hypercholesterolemia guidelines and FH Gulf registry. She is the National Lead investigator for FH in Bahrain.

Dr. Alsayed participated with expert panel and published first consensus recommendation for management of plasma lipid disorders for Middle East 2016. She has other several publications in the endocrine field.